Ada Edwards
Family · San Francisco, CANPI 1053869073
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 56 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 10.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,490, 5.0 times the $296 reported in 2021. Among family clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 56 payments — averaging $84.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$485
- Biotronik NRO, Inc.$321
- Sanofi$304
- Nevro Corp.$296
- Saluda Medical Americas, Inc.$294
- MML US, Inc.$201
- plus $3K from 26 others
What the payments were for
- Food & beverage$4,736100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 7 | $485 |
| Biotronik NRO, Inc. | 3 | $321 |
| Sanofi | 3 | $304 |
| Nevro Corp. | 3 | $296 |
| Saluda Medical Americas, Inc. | 4 | $294 |
| MML US, Inc. | 1 | $201 |
| Ultragenyx Pharmaceutical Inc. | 2 | $187 |
| Axsome Therapeutics, Inc. | 2 | $179 |
| Pfizer | 2 | $173 |
| Inspire Medical Systems, Inc. | 1 | $130 |
| Neurelis, Inc. | 2 | $127 |
| Pharmaessentia USA Corporation | 1 | $125 |
| Exact Sciences | 1 | $124 |
| Lexicon Pharmaceuticals, Inc. | 1 | $124 |
| Abbott | 6 | $122 |
| Argenx US, Inc. | 1 | $122 |
| Sage Therapeutics, LLC | 1 | $118 |
| Amarin Pharma, Inc. | 1 | $118 |
| GRT US Holding, Inc. | 1 | $115 |
| GSK | 1 | $114 |
| Gilead | 1 | $113 |
| Boehringer Ingelheim | 1 | $107 |
| Bioventus LLC | 1 | $103 |
| Hologic Sales And Service, LLC | 1 | $100 |
| Tonix Medicines, Inc. | 1 | $94 |
| Scynexis, Inc. | 1 | $88 |
| UCB, Inc. | 1 | $88 |
| Amgen | 1 | $85 |
| SPR Therapeutics, Inc | 1 | $65 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $54 |
| Boston Scientific | 1 | $31 |
| Tersera Therapeutics LLC | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,736 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 42 | $9,372 |
| Lidocaine | 17 | $3,939 |
| Pregabalin | 67 | $1,502 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 52 | $1,433 |
| Naloxone Hcl | 16 | $1,056 |
| Buprenorphine Hcl | 31 | $741 |
| Oxycodone Hcl | 50 | $481 |
| Tizanidine Hcl | 15 | $364 |
| Hydromorphone Hcl | 29 | $362 |
| Gabapentin | 19 | $318 |
| Tramadol Hcl | 23 | $312 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 26 | $94 |
| Meloxicam | 15 | $16 |
Paid to pharmacies, not to this prescriber.
Other family in San Francisco
- Gabriel SchwartzSan Francisco$166K
- Annika EhrlichSan Francisco$128K
- Monica VolzSan Francisco$96K
- Bethany KinseySan Francisco$33K
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.